Biotech solutions company
BiomX has raised €50M across 2 funding rounds from 7 investors, most recently a Series B round in Jan 2019. Based in Ness Ziona, Israel; active in Fintech and Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2019-01-01 | Series B | €28M | RM Global Partners,Seventure Partners | View deal → |
| 2017-05-16 | Series A | €22M | Innovation SBI Japan-Israel Innovation Fund,Johnson & Johnson,Mirae Asset Venture Investment,OrbiMed,Seventure Partners,Takeda Ventures | View deal → |
